Trademark: 79293512
Word
ABLIVA
Status
Registered
Status Code
700
Status Date
Tuesday, September 7, 2021
Serial Number
79293512
Registration Number
6473368
Registration Date
Tuesday, September 7, 2021
Mark Type
4000
Filing Date
Wednesday, July 15, 2020
Published for Opposition
Tuesday, June 22, 2021

Trademark Owner History
Abliva AB - Original Registrant

Classifications
42 Medical research; research relating to biotechnology; clinical research in the field of mitochondrial diseases; conducting clinical trials for pharmaceutical products for others

Trademark Events
Jan 1, 2023
New Representative At Ib Received
Mar 13, 2022
Final Decision Transaction Processed By Ib
Feb 22, 2022
Final Disposition Notice Sent To Ib
Feb 22, 2022
Final Disposition Processed
Dec 7, 2021
Final Disposition Notice Created, To Be Sent To Ib
Oct 28, 2021
New Representative At Ib Received
Sep 7, 2021
Registered-Principal Register
Jun 22, 2021
Official Gazette Publication Confirmation E-Mailed
Jun 22, 2021
Published For Opposition
Jun 2, 2021
Notification Of Notice Of Publication E-Mailed
May 17, 2021
Approved For Pub - Principal Register
May 15, 2021
Teas/Email Correspondence Entered
May 14, 2021
Correspondence Received In Law Office
May 14, 2021
Teas Response To Office Action Received
Dec 6, 2020
Refusal Processed By Ib
Nov 18, 2020
Non-Final Action Mailed - Refusal Sent To Ib
Nov 18, 2020
Refusal Processed By Mpu
Oct 29, 2020
Non-Final Action (Ib Refusal) Prepared For Review
Oct 28, 2020
Non-Final Action Written
Oct 28, 2020
Assigned To Examiner
Sep 22, 2020
Application Filing Receipt Mailed
Sep 18, 2020
New Application Office Supplied Data Entered In Tram
Sep 17, 2020
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24